Seeing Is Believing
Proteostasis Therapeutics's activity chart (see below) currently has 14 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 88.89% with an average time for these price targets to be met of 469.56 days.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 24-Aug-2020. First documented stock forecast 12-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Aug-2020
$3
5 years 11 months 10 days ago
(24-Aug-2020)
2/2 (100%)
$-159.4 (-98.15%)
532
Buy Since 07-Nov-2018
$4
$-150.7 (-97.41%)
6 years 6 months 5 days ago
(29-Jan-2020)
1/1 (100%)
$-241 (-98.37%)
324
Buy Since 18-Oct-2018
$8
$-146.7 (-94.83%)
$8
6 years 7 months 17 days ago
(17-Dec-2019)
3/3 (100%)
$-213.2 (-96.38%)
553
Buy Since 06-Nov-2018
$14
$-140.7 (-90.95%)
$21
7 years 4 months 9 days ago
(25-Mar-2019)
2/2 (100%)
$-169.4 (-92.37%)
704
Buy
$9
$-13.1 (-59.28%)
8 years 11 months 19 days ago
(16-Aug-2017)
0/1 (0%)
$-31.8 (-77.94%)
What is PTI (Proteostasis Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTI (Proteostasis Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTI (Proteostasis Therapeutics)?
Which analyst is the currently most bullish on PTI (Proteostasis Therapeutics)?
Which analyst is the currently most reserved on PTI (Proteostasis Therapeutics)?